The store will not work correctly when cookies are disabled.
N-(4-aminophenyl)-6-methyl-2-oxo-chromene-3-carboxamide
ID: ALA4743471
PubChem CID: 162645692
Max Phase: Preclinical
Molecular Formula: C17H14N2O3
Molecular Weight: 294.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc2oc(=O)c(C(=O)Nc3ccc(N)cc3)cc2c1
Standard InChI: InChI=1S/C17H14N2O3/c1-10-2-7-15-11(8-10)9-14(17(21)22-15)16(20)19-13-5-3-12(18)4-6-13/h2-9H,18H2,1H3,(H,19,20)
Standard InChI Key: BCOQZELHYUDVIX-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
9.1798 -11.8195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8929 -11.4093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6023 -11.8189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6023 -12.6444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8955 -13.0580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1798 -12.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3196 -13.0592 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0329 -12.6444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0329 -11.8190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3196 -11.4084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7460 -11.4084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7460 -10.5829 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4593 -11.8190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1766 -11.4084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1769 -10.5829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8877 -10.1709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6012 -10.5857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6034 -11.4054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8942 -11.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3186 -10.1710 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7460 -13.0592 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4624 -11.4089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
3 10 1 0
9 11 1 0
11 12 2 0
11 13 1 0
13 14 1 0
15 14 2 0
16 15 1 0
17 16 2 0
18 17 1 0
19 18 2 0
14 19 1 0
17 20 1 0
8 21 2 0
1 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.31 | Molecular Weight (Monoisotopic): 294.1004 | AlogP: 2.94 | #Rotatable Bonds: 2 |
Polar Surface Area: 85.33 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.75 | CX LogP: 2.49 | CX LogD: 2.49 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.56 | Np Likeness Score: -1.08 |
References
1. Davoine C,Bouckaert C,Fillet M,Pochet L. (2020) Factor XII/XIIa inhibitors: Their discovery, development, and potential indications., 208 [PMID:32883641] [10.1016/j.ejmech.2020.112753] |